Max Hodak
Chief Executive Officer
Max Hodak is the Co-Founder and CEO of Science Corporation, the pioneering full-stack neural engineering company focused on restoring and extending life by transcending the limits of biology. He started Science in 2021 to develop advanced neural engineering and brain-computer interface (BCI) technology.
The company’s PRIMA implant (featured in The New England Journal of Medicine and on the cover of TIME) is the first device to restore functional central vision and is the first brain-computer interface to be made widely available to patients. PRIMA had its commercial launch in Europe after receiving a CE (Conformité Européenne) mark. It is currently under U.S. FDA review. Science is also building biohybrid interfaces that use living neurons to connect with the brain, and its Vessel initiative is developing advanced perfusion circuits to support organ transplantation and critical care.
Max was named to the TIME100 Health, recognizing individuals who have most influenced global health. He has had a lifelong passion for BCI technology and before co-founding Science, he was a co-founder of Neuralink in 2016, where he served as President for four years.
Whilst studying biomedical engineering at Duke University’s Pratt School of Engineering, he was a research assistant in Miguel Nicolelis’s laboratory. He has studied and writes about the science of consciousness.
